Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2005 1
2006 5
2007 4
2008 4
2009 8
2010 13
2011 18
2012 13
2013 26
2014 35
2015 42
2016 32
2017 42
2018 46
2019 66
2020 74
2021 94
2022 71
Text availability
Article attribute
Article type
Publication date

Search Results

536 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNA-9 and breast cancer.
Li X, Zeng Z, Wang J, Wu Y, Chen W, Zheng L, Xi T, Wang A, Lu Y. Li X, et al. Among authors: wu y. Biomed Pharmacother. 2020 Feb;122:109687. doi: 10.1016/j.biopha.2019.109687. Epub 2019 Dec 30. Biomed Pharmacother. 2020. PMID: 31918267 Free article. Review.
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade.
Zhao M, Guo W, Wu Y, Yang C, Zhong L, Deng G, Zhu Y, Liu W, Gu Y, Lu Y, Kong L, Meng X, Xu Q, Sun Y. Zhao M, et al. Among authors: wu y. Acta Pharm Sin B. 2019 Mar;9(2):304-315. doi: 10.1016/j.apsb.2018.08.009. Epub 2018 Sep 5. Acta Pharm Sin B. 2019. PMID: 30972278 Free PMC article.
Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C, Ou R, Chen X, Zhang Y, Li J, Liang Y, Zhu X, Liu L, Li M, Lin D, Qiu J, Liu G, Zhang L, Wu Y, Tang H, Liu Y, Liang L, Ding Y, Liao W. Huang C, et al. Among authors: wu y. J Exp Clin Cancer Res. 2021 Sep 28;40(1):304. doi: 10.1186/s13046-021-02108-0. J Exp Clin Cancer Res. 2021. PMID: 34583750 Free PMC article.
536 results